Accuracy of real‐time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study

By G. Ferraioli, C. Tinelli, B. Dal Bello, M. Zicchetti, G. Filice, C. Fìlice. Hepatology, 2012

678 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

EFSUMB Guidelines and Recommendations on the Clinical Use of Ultrasound Elastography.Part 2: Clinical Applications (2013, positive): “2D-SWE using the Aixplorer ® system is reported in two studies in 133 and 121 patients with chronic hepatitis C (with 29% and 100% of patients having biopsy as gold standard) [52, 53].”
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. (2015, methodology): “In chronic hepatitis C [189], AUROCs of SWE were significantly higher than with TE for the diagnosis of significant fibrosis (0.”
WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. (2015, methodology): “Lastly, negative results should not be neglected (Ferraioli et al. 2012a; Friedrich-Rust et al. 2009b).”
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) (2017, methodology): “One study [107] evaluated factors that influenced the correlation of SWS assessed by VTQ ® with histological fibrosis in a cohort of 106 chronic hepatitis C (CHC) patients.”
Ultrasound Elastography: Review of Techniques and Clinical Applications (2017, methodology): “002) [20], with the optimal cut-off values for 2D-SWE summarized in Table 2.”